noscript

News and Announcements

Shivom Covered by CryptoCoin!

  • Published April 15, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Key Takeaways:

  • CryptoCoin covers Shivom, offering a review of the company
  • This feature shares information on Shivom’s panel of experts on board, insights about the OmiX token, partnerships, use of blockchain and its position among the noteworthy blockchain projects.

Shivom Cryptocoin

A leading news source for information on cryptocurrencies, ICO reviews, cryptonews, and blockchain projects, CryptoCoin.com has recently covered Shivom.

The article, offers a review of Shivom and its goal to build the world’s largest genomic data-hub and healthcare ecosystem; its new and unique global healthcare OmiX token, and its scope of improving precision medicine, DNA data analysis, and prognosis of various diseases using genomic data.

Throwing light on various aspects of Shivom as a DNA data-hub, a potential global health game-changer, and major new cryptocurrency project, the article presents a holistic view of Shivom’s capability and its prospects in the ICO market and as a driver of healthcare as it strategically integrates blockchain technology with DNA Data.

The article is a must-read for anyone who wants to be further informed about Shivom, the panel of experts on board, insights about the OmiX token, partnerships, use of blockchain and its position among the noteworthy blockchain projects.

An excerpt from the article states, “Shivom ecosystem will function in a decentralized way by using blockchain technologies, integrating the best protocols for advanced encryption and the combination of this with Artificial Intelligence.”

About Shivom

Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.

Request Offer

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now